Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FRMD1 Inhibitors

FRMD1 inhibitors represent a chemical class focused on the modulation of the FRMD1 protein, which is a member of the FERM domain-containing protein family. The FERM (4.1 protein, ezrin, radixin, moesin) domain is known for its involvement in linking the cytoskeleton to the plasma membrane, which is crucial for maintaining cellular structure and facilitating signal transduction processes. FRMD1, specifically, is implicated in various cellular functions, including cell adhesion, migration, and signaling pathways that are integral to maintaining cellular homeostasis. The role of FRMD1 in these processes suggests that inhibitors targeting this protein could potentially alter the dynamics of cytoskeletal arrangements and membrane associations, thereby impacting cellular behavior at a fundamental level. The precise structural characteristics of FRMD1 inhibitors are typically designed to interact with the FERM domain, preventing the proper association of FRMD1 with other cellular components. This interaction can lead to changes in the actin cytoskeleton and membrane-related signaling pathways, which are pivotal in numerous cellular processes. The design and development of FRMD1 inhibitors require a detailed understanding of the protein's structure, particularly the FERM domain, to identify key binding sites and to achieve the desired specificity. Structural biology techniques such as X-ray crystallography and cryo-electron microscopy are often employed to elucidate the three-dimensional conformation of FRMD1 and to inform the rational design of inhibitors. Additionally, biochemical assays are used to evaluate the efficacy of these inhibitors in modulating FRMD1 activity, providing insights into their potential impact on cellular processes. Furthermore, computational modeling and molecular dynamics simulations play a critical role in predicting the behavior of these inhibitors within a biological context, allowing for optimization of their interactions with FRMD1. The study of FRMD1 inhibitors is an area of active research, with ongoing efforts aimed at understanding the broader implications of FERM domain modulation and its effects on cellular architecture and signaling.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Inhibits protein kinases which could disrupt downstream signaling required for FRMD1 function.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Specifically inhibits Protein Kinase C, likely affecting signaling pathways involving FRMD1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K which is involved in signaling pathways that FRMD1 is part of, thus inhibiting FRMD1.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Blocks PI3K activity, impacting FRMD1's functional role in PI3K/AKT pathway signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK, which could lead to reduced ERK pathway activity, potentially inhibiting FRMD1.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAPK, likely disrupting signaling pathways that are necessary for FRMD1 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, potentially leading to inhibition of FRMD1's role in JNK pathway signaling.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Inhibits MLCK, potentially affecting cellular processes and signaling that involve FRMD1.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Inhibits ROCK, potentially disrupting cytoskeletal dynamics and signaling involving FRMD1.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Inhibits PKC, potentially disrupting signaling pathways integral to FRMD1's function.